Sinovac Biotech says its unit's Covid-19 vaccine has been formally approved for general public use by China medical product regulator, Reuters reported.

Prior to the approval, the CoronaVac vaccine had already been administered in China's vaccination programme mainly targeting key groups deemed to be at higher risk of exposure to the virus.